Trial intelligence / Profile preview

Buprenorphine for Rapid Opiate Detoxification and Naltrexone Induction

NCT00000299Phase 2Completed

Sponsor
University of California, Los Angeles
Start
Oct 2008
Primary completion
Nov 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of buprenorphine in opioid use disorder (OUD), sponsored by University of California, Los Angeles. Started Oct 2008; status: completed.

02

Drugs

buprenorphine
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT00000299.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000299.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call